Balyasny Asset Management LLC Crispr Therapeutics Ag Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Balyasny Asset Management LLC holds 623,650 shares of CRSP stock, worth $25.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

623,650

Previous 90,664 587.87%

Holding current value

$25.4 Million

Previous $4.9 Million 498.55%

% of portfolio

0.05%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$44.62 - $62.75 $23.8 Million - $33.4 Million	532,986 Added 587.87%	623,650 $29.3 Million
Q2 2024 Aug 14, 2024	BUY	$51.17 - $68.18 $4.64 Million - $6.18 Million	90,664 New	90,664 $4.9 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $1.65 Million - $2.76 Million	42,018 Added 186.23%	64,580 $2.63 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $1.38 Million - $1.89 Million	22,562 New	22,562 $1.48 Million
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $303,301 - $517,991	-7,016 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $62,179 - $92,631	1,169 Added 19.99%	7,016 $440,000
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $339,305 - $538,754	-4,841 Reduced 45.29%	5,847 $443,000
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $1.18 Million - $1.67 Million	10,688 New	10,688 $1.2 Million
Q1 2021 May 17, 2021	SELL	$110.72 - $210.04 $378,440 - $717,916	-3,418 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$79.67 - $173.23 $7.68 Million - $16.7 Million	-96,384 Reduced 96.58%	3,418 $523,000
Q3 2020 Nov 16, 2020	BUY	$78.5 - $100.64 $7.37 Million - $9.44 Million	93,839 Added 1573.69%	99,802 $8.35 Million
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $229,575 - $453,486	5,963 New	5,963 $438,000
Q3 2019 Nov 14, 2019	SELL	$40.99 - $52.56 $4.49 Million - $5.76 Million	-109,657 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$35.45 - $48.2 $3.89 Million - $5.29 Million	109,657 New	109,657 $5.17 Million

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.18B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Crispr Therapeutics Ag Transaction History